Relative effectiveness and the European pharmaceutical market
Year of publication: |
2011
|
---|---|
Authors: | Jönsson, Bengt |
Published in: |
The European journal of health economics : HEPAC ; health economics in prevention and care. - Berlin : Springer, ISSN 1618-7598, ZDB-ID 2045253-6. - Vol. 12.2011, 2, p. 97-102
|
Subject: | Arzneimittelmarkt | Pharmaceutical market | Pharmaindustrie | Pharmaceutical industry | Effizienzmarkthypothese | Efficient market hypothesis | EU-Staaten | EU countries |
-
Grünwald, Fabian, (2024)
-
Pharmaceutical regulation in Europe and its impact on corporate R&D
Eger, Stephan, (2014)
-
Challenges of the COVID-19 pandemic to pharmaceutical manufacturing : the EU and Ukraine's response
Salikhova, Olena, (2021)
- More ...
-
Jönsson, Bengt, (2002)
-
Costs and quality of life in multiple sclerosis: A cross-sectional observational study in Germany
Kobelt, Gisela, (2000)
-
Costs and quality of life in multiple sclerosis: A cross-sectional observational study in the UK
Kobelt, Gisela, (2000)
- More ...